Skip to main content
. 2013 Jan 15;52(5):916–923. doi: 10.1093/rheumatology/kes402

Table 4.

Univariate association of comorbidity with moderate to severe pain after revision TKA

2 years (n = 332/1494)
5 years (n = 207/843)
Variable n/N (%) Odds ratio (95% CI) P-value n/N (%) Odds ratio (95% CI) P-value
Heart disease (MI, CHF)
    No 314/1386 (22.7) Reference 196/798 (24.6) Reference
    Yes 18/106 (17) 0.7 (0.4, 1.2) 0.18 11/45 (24.4) 1.0 (0.5, 2.0) 0.99
Peripheral vascular disease
    No 323/1442 (22.4) Reference 202/824 (24.5) Reference
    Yes 9/50 (18) 0.8 (0.4, 1.6) 0.47 5/19 (26.3) 1.1 (0.4, 3.3) 0.86
Renal disease
    No 321/1428 (22.5) Reference 202/824 (24.5) Reference
    Yes 11/64 (17.2) 0.7 (0.4, 1.4) 0.31 5/19 (26.3) 1.1 (0.3, 3.5) 0.87
Chronic obstructive pulmonary disease
    No 294/1353 (21.7) Reference 195/771 (25.3) Reference
    Yes 38/139 (27.3) 1.4 (0.9, 2.0) 0.14 12/72 (16.7) 0.6 (0.3, 1.1) 0.10
Diabetes (with or without organ damage)
    No 298/1338 (22.3) Reference 188/780 (24.1) Reference
    Yes 34/154 (22.1) 1.0 (0.7, 1.5) 0.96 19/63 (30.2) 1.4 (0.8, 2.4) 0.29
CTD
    No 317/1378 (23) Reference 197/777 (25.4) Reference
    Yes 15/114 (13.2) 0.5 (0.3, 0.9)* 0.02 10/66 (15.2) 0.5 (0.2, 1.1) 0.09
Depression
    No 294/1377 (21.4) Reference 193/797 (24.2) Reference
    Yes 38/117 (32.5) 1.8 (1.1, 2.7)* <0.01 14/47 (29.8) 1.3 (0.7, 2.6) 0.40
Anxiety
    No 308/1423 (21.6) Reference 199/817 (24.4) Reference
    Yes 24/71 (33.8) 1.8 (1.1, 3.1)* 0.02 8/27 (29.6) 1.3 (0.5, 3.4) 0.58

*Significant values.